These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24171573)
41. Epidemiologic relatedness between Brucella abortus isolates from livestock and wildlife in South Korea. Kim JY; Her M; Kang SI; Lee K; Lee HK; Jung SC J Wildl Dis; 2013 Apr; 49(2):451-4. PubMed ID: 23568927 [TBL] [Abstract][Full Text] [Related]
42. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Cheville NF; Stevens MG; Jensen AE; Tatum FM; Halling SM Am J Vet Res; 1993 Oct; 54(10):1591-7. PubMed ID: 8250382 [TBL] [Abstract][Full Text] [Related]
43. Identification of Brucella abortus virulence proteins that modulate the host immune response. Wang Y; Chen Z; Qiu Y; Ke Y; Xu J; Yuan X; Li X; Fu S; Cui M; Xie Y; Du X; Wang Z; Huang L Bioengineered; 2012; 3(5):303-5. PubMed ID: 22743689 [TBL] [Abstract][Full Text] [Related]
44. Observations on the use of GonaCon in captive female elk (Cervus elaphus). Killian G; Kreeger TJ; Rhyan J; Fagerstone K; Miller L J Wildl Dis; 2009 Jan; 45(1):184-8. PubMed ID: 19204347 [TBL] [Abstract][Full Text] [Related]
45. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle. Olsen SC Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581 [TBL] [Abstract][Full Text] [Related]
46. Outcome and immune responses after Brucella abortus infection in young adult and aged mice. High KP; Prasad R; Marion CR; Schurig GG; Boyle SM; Sriranganathan N Biogerontology; 2007 Oct; 8(5):583-93. PubMed ID: 17653832 [TBL] [Abstract][Full Text] [Related]
47. The role of a Brucella abortus lipoprotein in intracellular replication and pathogenicity in experimentally infected mice. Kim DH; Son BG; Lim JJ; Lee JJ; Kim DG; Lee HJ; Min W; Rhee MH; Kim KD; Chang HH; Kim S Microb Pathog; 2013 Jan; 54():34-9. PubMed ID: 23006628 [TBL] [Abstract][Full Text] [Related]
49. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544. Goel D; Rajendran V; Ghosh PC; Bhatnagar R Vaccine; 2013 Feb; 31(8):1231-7. PubMed ID: 23273966 [TBL] [Abstract][Full Text] [Related]
50. Application of pulsed-field gel electrophoresis for differentiation of vaccine strain RB51 from field isolates of Brucella abortus from cattle, bison, and elk. Jensen AE; Cheville NF; Ewalt DR; Payeur JB; Thoen CO Am J Vet Res; 1995 Mar; 56(3):308-12. PubMed ID: 7771697 [TBL] [Abstract][Full Text] [Related]
51. Brucella abortus in captive bison. I. Serology, bacteriology, pathogenesis, and transmission to cattle. Davis DS; Templeton JW; Ficht TA; Williams JD; Kopec JD; Adams LG J Wildl Dis; 1990 Jul; 26(3):360-71. PubMed ID: 2117675 [TBL] [Abstract][Full Text] [Related]
52. Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety. Khalaf OH; Chaki SP; Garcia-Gonzalez DG; Suva LJ; Gaddy D; Arenas-Gamboa AM Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932325 [TBL] [Abstract][Full Text] [Related]
53. Host interferon-γ inducible protein contributes to Brucella survival. Ritchie JA; Rupper A; Cardelli JA; Bellaire BH Front Cell Infect Microbiol; 2012; 2():55. PubMed ID: 22919646 [TBL] [Abstract][Full Text] [Related]
54. Human exposure to Brucella abortus strain RB51--Kansas, 1997. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(9):172-5. PubMed ID: 9518281 [TBL] [Abstract][Full Text] [Related]
55. Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice. Brandão AP; Oliveira FS; Carvalho NB; Vieira LQ; Azevedo V; Macedo GC; Oliveira SC Clin Dev Immunol; 2012; 2012():589494. PubMed ID: 22194770 [TBL] [Abstract][Full Text] [Related]
56. Brucellosis in elk of eastern Idaho. Etter RP; Drew ML J Wildl Dis; 2006 Apr; 42(2):271-8. PubMed ID: 16870849 [TBL] [Abstract][Full Text] [Related]
57. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155 [TBL] [Abstract][Full Text] [Related]
58. The immunomodulatory effect of antimicrobial peptide HPA3P restricts Brucella abortus 544 infection in BALB/c mice. Arayan LT; Kim HB; Bernardo Reyes AW; Xuan Huy NT; Hong IH; Lee K; Yeom JH; Park Y; Kim S Vet Microbiol; 2018 Nov; 225():17-24. PubMed ID: 30322527 [TBL] [Abstract][Full Text] [Related]
59. Brucella vaccines in wildlife. Davis DS; Elzer PH Vet Microbiol; 2002 Dec; 90(1-4):533-44. PubMed ID: 12414169 [TBL] [Abstract][Full Text] [Related]
60. Brucellosis in elk I. Serologic and bacteriologic survey in Wyoming. Thorne ET; Morton JK; Thomas GM J Wildl Dis; 1978 Jan; 14(1):74-81. PubMed ID: 416232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]